[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
May 1994

A Major Barrier to Universal Hepatitis B Immunization of Infants

Author Affiliations

Vaccine Unit Department of Pediatrics Duke University Medical Center 1830 Hillondale Rd Durham, NC 27705

Arch Pediatr Adolesc Med. 1994;148(5):538-539. doi:10.1001/archpedi.1994.02170050096023

In accordance with the Immunization Practices Advisory Committee recommendations for universal infant vaccination with hepatitis B vaccine,1 Duke University Medical Center (DUMC), Durham, NC, began in February 1993 to offer hepatitis B vaccine for all infants prior to being discharged from the hospital at birth. Of the 715 children born at DUMC between March 1, 1993, and June 30, 1993,513 (71.7%) received a first dose of hepatitis B vaccine.

According to the Immunization Practices Advisory Committee recommendations, doses two and three of hepatitis B vaccine are to be given at ages 1 to 2 months and 6 to 18 months, respectively. At the DUMC pediatrie practice, all children who are recipients of Medicaid are routinely immunized with vaccines other than hepatitis B, starting at age 2 months. All vaccines, including the Haemophilus Influenzae type b oligosaccharide

CRMj97 conjugate vaccine, are supplied by the Durham County Health Department. However, to